REVIEW
Published on 08 Jul 2025
Synergy of oncolytic adenovirus and immune checkpoint inhibitors: transforming cancer immunotherapy paradigms
doi 10.3389/fimmu.2025.1610858
- 351 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Breakthroughs in Immune Checkpoint Therapy: Overcoming Resistance with Novel Techniques
Breakthroughs in Immune Checkpoint Therapy: Overcoming Resistance with Novel Techniques
874
Total downloads
5,603
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 08 Jul 2025
Efficacy of irreversible electroporation combined with immunotherapy versus irreversible electroporation alone in locally advanced pancreatic cancer: a propensity score-matched retrospective study
doi 10.3389/fimmu.2025.1620988
- 359 views
REVIEW
Published on 02 Jul 2025
CAR-T therapy-based innovations in the enhancement of contemporary anti-tumor therapies
doi 10.3389/fimmu.2025.1622433
- 727 views
MINI REVIEW
Accepted on 23 Jun 2025
Fluorinated Small Molecule Derivatives in Cancer Immunotherapy: Emerging Frontiers and Therapeutic Potential
doi 10.3389/fimmu.2025.1622091
- 217 views
ORIGINAL RESEARCH
Published on 11 Jun 2025
PA/MR imaging-guided precision phototherapy and efficacy evaluation of hepatocellular carcinoma utilizing a targeted multifunctional nanoprobe
doi 10.3389/fimmu.2025.1605048
- 631 views
ORIGINAL RESEARCH
Published on 09 May 2025
The bispecific antibody targeting VISTA and PD-L1 shows enhanced tumor inhibitory activity in pancreatic, endometrial and breast cancers compared to mono- and combination immune checkpoint blockade
doi 10.3389/fimmu.2025.1486799
- 1,454 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: